Orthoforge Inc.

Orthoforge Inc. is a pre-clinical development stage medical device company with the slogan "Bone and Soft Tissue Healing Analysis." Founded in 2019 and headquartered in the United States, the company is focused on using patented ultrasound-based technology to measure the healing stage of bone and soft tissues following an injury.

Utilizing ultrasound, a technology well-established in medicine, Orthoforge aims to provide a radiation-free method for monitoring the progress of healing in bone and soft tissue injuries. This approach offers a quantifiable reading that enables doctors to assess the healing progress. The initial application of this technology is to identify and analyze the healing of long bone fractures (e.g., thighs, shins, fingers, arms), with future plans to expand to other bone and soft tissue injuries. The company's innovative approach leverages the unique properties of bone and soft tissues, which can be differentiated by sound waves.

The last investment received by Orthoforge Inc. was a Seed Round investment on July 18, 2017, led by Ben Franklin Technology Partners of Northeastern Pennsylvania.

In summary, Orthoforge Inc. is positioning itself as a promising player in the intersection of Health Care and Information Technology, leveraging ultrasound technology to revolutionize the monitoring and analysis of bone and soft tissue healing.